SNS Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-8,900
Closed -$1.32M 219
2020
Q3
$1.32M Buy
+8,900
New +$1.38M 0.21% 67
2020
Q2
Sell
-9,700
Closed -$1.35M 209
2020
Q1
$1.35M Sell
9,700
-1,100
-10% -$151K 0.26% 72
2019
Q4
$1.42M Buy
+10,800
New +$1.25M 0.25% 65

Other funds holding LLY

SNS Financial Group's LLY Position: Q1 2026 in Review

SNS Financial Group increased its Eli Lilly (LLY) stake by 1.4% in Q1 2026, buying an estimated $21.3K and bringing the position to 1,546 shares worth $1.42M. The position accounts for 0.12% of the portfolio, ranked #70.

SNS Financial Group first reported a position in LLY in Q2 2015 and has held it in 26 quarters since. The position peaked at $2.33M in Q4 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • SNS Financial Group held 1,546 shares of Eli Lilly worth $1.42M as of Q1 2026.
  • SNS Financial Group bought 21 Eli Lilly shares in Q1 2026, an estimated $21.3K.
  • Eli Lilly made up 0.12% of SNS Financial Group's portfolio in Q1 2026, its #70 holding.
  • SNS Financial Group first reported a position in Eli Lilly in Q2 2015 and has held it in 26 quarters since.
  • SNS Financial Group's Eli Lilly position peaked at $2.33M in Q4 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.